Cullen/Frost Bankers, Inc. Becton Dickinson & CO Transaction History

Cullen/Frost Bankers, Inc.

$7.23 Billion
Q3 2024

A detailed history of Cullen/Frost Bankers, Inc. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 5,712 shares of BDX stock, worth $1.31 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

5,712

Previous 6,049 5.57%

Holding current value

$1.31 Million

Previous $1.41 Million 2.55%

% of portfolio

0.02%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$221.47 - $242.41 $74,635 - $81,692	-337 Reduced 5.57%	5,712 $1.38 Million
Q2 2024 Aug 05, 2024	BUY	$225.07 - $246.17 $15,529 - $16,985	69 Added 1.15%	6,049 $1.41 Million
Q1 2024 May 10, 2024	SELL	$233.45 - $247.73 $46,690 - $49,546	-200 Reduced 3.24%	5,980 $1.48 Million
Q4 2023 Feb 06, 2024	SELL	$232.24 - $267.23 $96,844 - $111,434	-417 Reduced 6.32%	6,180 $1.51 Million
Q3 2023 Nov 02, 2023	SELL	$254.9 - $283.59 $73,411 - $81,673	-288 Reduced 4.18%	6,597 $1.71 Million
Q2 2023 Aug 04, 2023	SELL	$238.39 - $265.32 $85,105 - $94,719	-357 Reduced 4.93%	6,885 $1.82 Million
Q1 2023 May 05, 2023	SELL	$229.71 - $259.35 $31,699 - $35,790	-138 Reduced 1.87%	7,242 $1.79 Million
Q4 2022 Feb 13, 2023	SELL	$218.29 - $256.91 $166,773 - $196,279	-764 Reduced 9.38%	7,380 $1.88 Million
Q3 2022 Nov 07, 2022	SELL	$51.03 - $264.23 $4,133 - $21,402	-81 Reduced 0.98%	8,144 $1.82 Million
Q2 2022 Aug 05, 2022	SELL	$234.74 - $275.42 $61,736 - $72,435	-263 Reduced 3.1%	8,225 $2.03 Million
Q1 2022 May 09, 2022	SELL	$243.64 - $270.48 $148,620 - $164,992	-610 Reduced 6.7%	8,488 $2.26 Million
Q4 2021 Feb 07, 2022	BUY	$230.08 - $250.94 $48,086 - $52,446	209 Added 2.35%	9,098 $2.29 Million
Q3 2021 Nov 04, 2021	SELL	$232.72 - $256.47 $275,773 - $303,916	-1,185 Reduced 11.76%	8,889 $2.19 Million
Q2 2021 Aug 05, 2021	SELL	$232.65 - $254.58 $962,240 - $1.05 Million	-4,136 Reduced 29.11%	10,074 $2.45 Million
Q1 2021 May 05, 2021	SELL	$232.09 - $256.88 $550,053 - $608,805	-2,370 Reduced 14.29%	14,210 $3.46 Million
Q4 2020 Feb 08, 2021	SELL	$221.92 - $245.94 $1.2 Million - $1.33 Million	-5,408 Reduced 24.6%	16,580 $4.15 Million
Q3 2020 Nov 05, 2020	SELL	$215.77 - $276.76 $1.1 Million - $1.41 Million	-5,111 Reduced 18.86%	21,988 $5.12 Million
Q2 2020 Aug 05, 2020	SELL	$219.9 - $263.41 $1.02 Million - $1.22 Million	-4,621 Reduced 14.57%	27,099 $6.48 Million
Q1 2020 May 01, 2020	SELL	$195.69 - $279.01 $9.42 Million - $13.4 Million	-48,145 Reduced 60.28%	31,720 $7.29 Million
Q4 2019 Feb 06, 2020	SELL	$236.45 - $266.82 $642,907 - $725,483	-2,719 Reduced 3.29%	79,865 $21.7 Million
Q3 2019 Nov 01, 2019	SELL	$230.58 - $256.08 $58,797 - $65,300	-255 Reduced 0.31%	82,584 $20.9 Million
Q2 2019 Aug 01, 2019	SELL	$217.4 - $246.08 $1.01 Million - $1.15 Million	-4,656 Reduced 5.32%	82,839 $20.9 Million
Q1 2019 Apr 30, 2019	SELL	$206.05 - $248.17 $287,851 - $346,693	-1,397 Reduced 1.57%	87,495 $21.9 Million
Q4 2018 Feb 06, 2019	SELL	$204.73 - $257.93 $446,720 - $562,803	-2,182 Reduced 2.4%	88,892 $20 Million
Q3 2018 Oct 29, 2018	SELL	$233.07 - $256.0 $860,494 - $945,152	-3,692 Reduced 3.9%	91,074 $23.8 Million
Q2 2018 Jul 27, 2018	SELL	$208.1 - $233.85 $1.85 Million - $2.08 Million	-8,880 Reduced 8.57%	94,766 $22.7 Million
Q1 2018 May 11, 2018	BUY	$205.46 - $240.27 $4.78 Million - $5.59 Million	23,279 Added 28.97%	103,646 $22.5 Million
Q4 2017 Jan 31, 2018	SELL	$189.0 - $222.64 $3,024 - $3,562	-16 Reduced 0.02%	80,367 $17.2 Million
Q3 2017 Nov 02, 2017	BUY	$186.89 - $198.9 $15 Million - $16 Million	80,383	80,383 $15.8 Million

Others Institutions Holding BDX

# of Institutions

1,738

Shares Held

249M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $65.2B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.

Account

Cullen/Frost Bankers, Inc. Becton Dickinson & CO Transaction History